Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
Go back to Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026| (NASDAQ: LYEL) | Delayed: 11.61 -0.88 (7.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.49 | 52 Week High | $ | |||
| Open | $12.38 | 52 Week Low | $ | |||
| Day High | $12.68 | P/E | N/A | |||
| Day Low | $11.47 | EPS | $ | |||
| Volume | 1,574,434 | |||||

